Key Financial Data Of Reporting Company

KYORIN Pharmaceutical Co., Ltd. - Filing #7739072

Concept 2016-04-01 to
2017-03-31
As at
2017-03-31
As at
2017-03-31
2016-04-01 to
2017-03-31
As at
2016-03-31
As at
2016-03-31
2015-04-01 to
2016-03-31
2015-04-01 to
2016-03-31
2014-04-01 to
2015-03-31
2014-04-01 to
2015-03-31
As at
2015-03-31
As at
2015-03-31
2013-04-01 to
2014-03-31
As at
2014-03-31
2013-04-01 to
2014-03-31
As at
2014-03-31
2012-04-01 to
2013-03-31
As at
2013-03-31
As at
2013-03-31
2012-04-01 to
2013-03-31
Key financial data of reporting company
Business results of reporting company
Net sales
7,936,000,000 JPY
115,373,000,000 JPY
9,262,000,000 JPY
119,483,000,000 JPY
9,336,000,000 JPY
113,121,000,000 JPY
8,640,000,000 JPY
111,400,000,000 JPY
107,031,000,000 JPY
15,654,000,000 JPY
Ordinary profit (loss)
4,821,000,000 JPY
10,874,000,000 JPY
6,185,000,000 JPY
19,995,000,000 JPY
6,282,000,000 JPY
15,490,000,000 JPY
5,683,000,000 JPY
18,281,000,000 JPY
18,676,000,000 JPY
13,216,000,000 JPY
Profit (loss)
4,954,000,000 JPY
6,199,000,000 JPY
6,198,000,000 JPY
5,392,000,000 JPY
12,973,000,000 JPY
Share capital
700,000,000 JPY
700,000,000 JPY
700,000,000 JPY
700,000,000 JPY
700,000,000 JPY
Total number of issued shares
74,947,628 xbrli:shares
74,947,628 xbrli:shares
74,947,628 xbrli:shares
74,947,628 xbrli:shares
74,947,628 xbrli:shares
Net assets
157,837,000,000 JPY
104,070,000,000 JPY
103,036,000,000 JPY
157,049,000,000 JPY
100,147,000,000 JPY
148,600,000,000 JPY
137,821,000,000 JPY
100,767,000,000 JPY
99,112,000,000 JPY
129,099,000,000 JPY
Total assets
192,668,000,000 JPY
106,122,000,000 JPY
105,582,000,000 JPY
197,825,000,000 JPY
103,138,000,000 JPY
183,383,000,000 JPY
169,378,000,000 JPY
101,473,000,000 JPY
99,587,000,000 JPY
154,968,000,000 JPY
Net assets per share
2,146.83
1,401.01
1,389.40
2,131.67
1,354.11
2,009.45
1,844.61
1,348.56
1,326.40
1,727.86
Dividend paid per share
58
58
52
52
50
Interim dividend paid per share
20
20
20
10
10
Basic earnings (loss) per share
66.76
99.45
83.70
184.28
83.04
161.63
72.17
160.95
166.25
173.63
Diluted earnings per share
Equity-to-asset ratio
0.819 xbrli:pure
0.981 xbrli:pure
0.976 xbrli:pure
0.794 xbrli:pure
0.971 xbrli:pure
0.810 xbrli:pure
0.814 xbrli:pure
0.993 xbrli:pure
0.995 xbrli:pure
0.833 xbrli:pure
Rate of return on equity
0.048 xbrli:pure
0.046 xbrli:pure
0.061 xbrli:pure
0.089 xbrli:pure
0.062 xbrli:pure
0.084 xbrli:pure
0.054 xbrli:pure
0.090 xbrli:pure
0.100 xbrli:pure
0.138 xbrli:pure
Price-earnings ratio
35.22 xbrli:pure
23.64 xbrli:pure
25.62 xbrli:pure
11.63 xbrli:pure
34.61 xbrli:pure
17.78 xbrli:pure
27.31 xbrli:pure
12.25 xbrli:pure
13.82 xbrli:pure
13.24 xbrli:pure
Payout ratio
0.875 xbrli:pure
0.699 xbrli:pure
0.627 xbrli:pure
0.721 xbrli:pure
0.288 xbrli:pure
Net cash provided by (used in) operating activities
16,386,000,000 JPY
11,137,000,000 JPY
6,391,000,000 JPY
19,293,000,000 JPY
11,544,000,000 JPY
Net cash provided by (used in) investing activities
-13,142,000,000 JPY
650,000,000 JPY
-1,364,000,000 JPY
-2,477,000,000 JPY
-7,187,000,000 JPY
Net cash provided by (used in) financing activities
-5,721,000,000 JPY
-2,245,000,000 JPY
-5,233,000,000 JPY
-3,704,000,000 JPY
-5,132,000,000 JPY
Cash and cash equivalents
42,499,000,000 JPY
45,043,000,000 JPY
35,727,000,000 JPY
35,828,000,000 JPY
22,543,000,000 JPY
Number of employees
2,382 xbrli:pure
121 xbrli:pure
120 xbrli:pure
2,420 xbrli:pure
118 xbrli:pure
2,445 xbrli:pure
2,452 xbrli:pure
119 xbrli:pure
76 xbrli:pure
2,444 xbrli:pure
Average number of temporary employees
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
263 xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.